Improving HIV prevention for women who use drugs in Tanzania
Optimizing PrEP Engagement Among Women Who Use Drugs in Tanzania
This study is all about helping women in Tanzania who use heroin to better access and stick with HIV prevention methods like PrEP, especially by providing support for those dealing with mental health challenges like depression and anxiety.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10890024 on NIH RePORTER |
What this research studies
This research focuses on enhancing the engagement of women who use drugs, particularly heroin, in HIV prevention strategies like pre-exposure prophylaxis (PrEP) in Tanzania. It recognizes that mental health issues such as depression and anxiety can hinder these women's ability to access and adhere to PrEP. The study will adapt motivational interviewing and cognitive-behavioral therapy techniques for use by trained paraprofessionals to support these women in overcoming barriers to PrEP engagement. By tailoring these interventions to the specific needs of this vulnerable population, the research aims to improve their health outcomes significantly.
Who could benefit from this research
Good fit: Ideal candidates for this research are women over 21 years old who use drugs and are at risk of HIV infection.
Not a fit: Patients who do not use drugs or are not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased PrEP uptake and better health outcomes for women who use drugs in Tanzania, ultimately reducing the incidence of HIV.
How similar studies have performed: Previous research has shown success in using motivational interviewing and cognitive-behavioral therapy to improve health outcomes in similar populations, indicating a promising approach.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Saleem, Haneefa Tasleem — Johns Hopkins University
- Study coordinator: Saleem, Haneefa Tasleem
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.